CataX1 min read
CataX AI raises RMB 40 million to bring AI agents into clinical drug development
Shanghai-based CataX AI has raised RMB 40 million in a seed round from Qiming Venture Partners, which incubated the startup and was the sole investor. CataX AI plans to license or co-develop drug candidates at the preclinical or early clinical stage and advance them through clinical proof of…
By TechNode FeedTechNode - China AI

Read the full story
Originally published by TechNode - China AI on Nov 16, 2026.
Comments
Sign in to join the discussion.